ORAGENICS, INC. Operating Lease Liability
ORAGENICS, INC. (OGEN) had Operating Lease Liability of $9.81 thousand as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-03-29
- 2023-12-31: Operating Lease, Liability $9.81K.
- 2023-09-30: Operating Lease, Liability $24.34K.
- 2023-06-30: Operating Lease, Liability $255.99K.
- 2023-03-31: Operating Lease, Liability $306.65K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2023-12-31 | $9.81K 10-K · filed 2024-03-29 | |
| 2023-09-30 | $24.34K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $255.99K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $306.65K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $356.89K 10-K · filed 2023-04-17 | |
| 2022-09-30 | $406.57K 10-Q/A · filed 2023-04-14 | |
| 2021-12-31 | $446.46K 10-Q/A · filed 2023-04-14 | $493.79K 10-K · filed 2022-03-24 |
| 2021-09-30 | $539.38K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $583.87K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $627.72K 10-Q · filed 2021-05-03 | |
| 2020-12-31 | $670.69K 10-K · filed 2021-03-01 | |
| 2020-09-30 | $712.92K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $754.55K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $795.59K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $835.79K 10-K · filed 2020-03-04 | |
| 2019-09-30 | $721.29K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $756.48K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $132.47K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |